European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

BACKGROUND AND AIM: Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor (erenumab) and three targeting the calcitonin gene-...

Descripción completa

Detalles Bibliográficos
Autores principales: Sacco, Simona, Bendtsen, Lars, Ashina, Messoud, Reuter, Uwe, Terwindt, Gisela, Mitsikostas, Dimos-Dimitrios, Martelletti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2019
Materias:
Consensus Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734227/
https://www.ncbi.nlm.nih.gov/pubmed/30651064
http://dx.doi.org/10.1186/s10194-018-0955-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734227/
https://www.ncbi.nlm.nih.gov/pubmed/30651064
http://dx.doi.org/10.1186/s10194-018-0955-y

Ejemplares similares